By: Danielle Kays and Kristin Stokes

Seyfarth Synopsis: While the plaintiffs’ bar has aggressively pursued class actions under the Biometric Information Privacy Act (“BIPA”) in recent years, these cases soon may be rivaled by the influx of class actions brought under the Genetic Information Privacy Act (“GIPA”), 410 Ill. Comp. Stat. Ann. 513/1, et seq. After GIPA’s 1998 enactment, only two cases were brought under the statute in nearly 25 years; however, in 2023, over 40 GIPA class action complaints have been filed in Illinois courts.
What is the Illinois Genetic Information Privacy Act (GIPA)?
GIPA was intended to facilitate voluntary and confidential genetic testing by providing protection from discriminatory use or disclosure of such information. In the employment context, GIPA bars employers from directly or indirectly acquiring “genetic testing or genetic information” from a prospective or current employee. See 410 ILCS 513/25(c)(1). In 2008, GIPA was amended to more closely conform to a later, federal analog—the Genetic Information Nondiscrimination Act (“GINA”). Both GINA and GIPA prohibit employer discrimination because of “genetic information” including: information about an individual or family member’s genetic test, request for genetic services, or manifestation of a disease or disorder. See 45 CFR 160.103. GIPA provides for a private right of action to “any person aggrieved by a violation of this Act . . . .” 410 ILCS 513/40.
This sudden influx of GIPA class actions likely are the result of steep statutory damages and a broad private right of action. While monetary damages are limited under GINA, GIPA contemplates no statutory cap and provides for damages of $2,500 per negligent violation or actual damages, whichever is greater. Moreover, an employer may be liable for $15,000 per intentional or reckless violation. 410 ILCS 513/40(a). GIPA even provides for significantly greater statutory damages than popular class action vehicle, BIPA. See 740 ILCS 14/20.
Current litigation also may be fueled by a recent decision in the case Bridges v. Blackstone Group, Inc., No. 21-cv-1091, 2022 WL 2643968 (S.D. Ill. 2022), establishing a broad class of possible claimants. In Bridges, plaintiffs brought a class action, alleging that Blackstone violated GIPA when it acquired Ancestry.com. The complaint was ultimately dismissed for failure to state a plausible violation of GIPA. Bridges, 2022 WL 2643968 at *2. However, the court first addressed whether the plaintiffs were “aggrieved persons” for purposes of bringing a claim. See 410 ILCS 513/40. The court adopted the Illinois Supreme Court’s definition of “aggrieved person” under BIPA. Accordingly, “an individual need not allege some actual injury or adverse effect, beyond violation of his or her rights.” Bridges, 2022 WL 2643968 at *2 (citing to Rosenbach v. Six Flags Ent. Corp., 129 N.E. 3d 1197 (Ill. 2019)).
Relatedly, genetic information and post-offer medical exams recently crossed the radar of the EEOC. Last month, the EEOC settled a case for alleged unlawful post-offer medical exams that required applicants to divulge family history of cancer, diabetes, and heart disease. See EEOC Press Release, Dollar General to Pay $1 Million to Settle EEOC Disability and GINA Lawsuit, https://www.eeoc.gov/newsroom/dollar-general-pay-1-million-settle-eeoc-disability-and-gina-lawsuit (Oct. 19, 2023).
Perhaps spurred by the breadth of potential claimants, and in the wake of several Illinois Supreme Court plaintiff-friendly BIPA decisions (Cothron v. White Castle and Tims v. Black Horse) and the first BIPA jury verdict (Rogers v. BNSF Railway Co.), plaintiffs firms have doggedly filed more than 40 GIPA class actions pending in Illinois courts. Utilizing nearly identical format, these complaints allege that large employers and companies solicited, requested, or required employee disclosure of genetic information. Specifically, these cases pursue generous statutory damages for GIPA violations arising out of required pre-employment physical exams, interviews, and questionnaires seeking family medical history.
Implications for Employers
In light of trending GIPA class actions, Illinois employers should exercise caution when requiring employees to submit to physical exams, inquiries, or screenings. Although courts have yet to resolve many legal defenses to these claims, targets of GIPA lawsuits may be vulnerable to significant exposure as plaintiffs allege that they are not required to prove actual injury. Businesses should review current hiring policies and procedures for compliance with this state genetic privacy law.
For more information about the GIPA and how genetic information laws may affect your business, contact the authors Danielle Kays and Kristin Stokes, your Seyfarth attorney, or Seyfarth’s Workplace Privacy & Biometrics Practice Group.


By 
Texas – The Texas Biometric Privacy Act prohibits the “capture” of biometric identifiers for a “commercial purpose” without notice and consent. The Act defines “biometric identifiers” as specifically “a retina or iris scan, fingerprint, voiceprint, or record of hand or face geometry.” “Commercial purpose” is left undefined in the statute. The law does not define whether notice and consent must be done in writing. Only the attorney general can bring suit for violations of the Act. Each violation is subject to a civil penalty of up to $25,000.
Washington – Washington prohibits the collection and use of biometric identifiers for commercial purposes without notice and consent. Unlike Texas’s law, Washington restricts the “enrollment” of biometric identifiers, which is defined as “capturing” a biometric identifier or “convert[ing] it into a reference template.” The law does not define whether notice and consent must be done in writing. However, notice and consent provisions do not apply to data collected for “security purposes” (i.e. stored for “the purpose of preventing shoplifting, fraud, or any other misappropriation or theft of a thing of value”). The law does not have a private right of action to allow for suits by individual plaintiffs. Instead, only the Washington Attorney General can enforce the requirements.
Arkansas – On April 15, 2019, Governor Asa Hutchinson signed
California – On June 28, 2018, California passed the
Alaska – Alaska’s biometric privacy bill,
Arizona – On January 22, 2019,
Massachusetts – Massachusetts’ proposed legislation,
Michigan – Michigan’s biometric privacy law,
New Hampshire – Though a BIPA-like law has not been introduced since 2017, there have been more recent attempts at prohibiting the collection of biometric information. This year,
New York – New York has two different biometric privacy bills pending in their legislature. On January 11, 2019, NY SB 1203 was introduced for the third time in just as many years. Like the bill pending in Michigan, the text of the New York bill is nearly identical to the BIPA, and includes a private right of action.
Perhaps the most striking trend of all is the substantial increase in class action filings under the BIPA since the Illinois Supreme Court’s decision in Rosenbach. Since this decision was issued on January 25, 2019, there have been a total of 151 class actions under the BIPA filed in Illinois – approximately a rate of an additional case filed every day. In fact, in just 148 days following the Rosenbach decision, the Illinois plaintiff’s bar filed nearly as many class action lawsuits under the BIPA as it did during a 10-year span prior to the decision. The pie graph below offers a visual account of this prompt spike in litigation activity. It has become clear to all Illinois businesses utilizing biometric technology that the plaintiff’s bar views the Rosenbach decision as a “door-opener” for class action filings under the BIPA.



By
By
By